Viela Bio surges after announcing Horizon will acquire the company for $53.00 per share in cash Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Tesla (TSLA) up 3% after Piper Sandler analyst Alexander Potter raised the firm's price target on shares to $1,200 from $515 and maintained an Overweight rating on the shares
- Viela Bio (VIE) up 52% after Horizon Therapeutics (HZNP) and the company announced they have entered into a definitive agreement under which Horizon will acquire all of the issued and outstanding shares of Viela Bio common stock for $53.00 per share in cash
- Tuscan Holdings Corp. (THCB) up 42% after Microvast and the company announced that they have entered into a definitive merger agreement that will result in Microvast becoming a publicly listed company
- NIO (NIO) up 3% after announcing it delivered 7,225 vehicles in January, up 352%
- Xpeng (XPEV) up 5% after announcing it delivered 6,015 Smart EVs in January, up 470%
UP AFTER EARNINGS -
- Thermo Fisher (TMO) up 1%
- Otis Worldwide (OTIS) up 1%
LOWER -
- Concert Pharmaceuticals (CNCE) down 41% after announcing that its Phase 2 clinical trial to evaluate CTP-692 as an adjunctive treatment in patients with schizophrenia did not meet the primary endpoint or other secondary endpoints
- GSX Techedu (GSX) down 5% after JPMorgan analyst DS Kim downgraded the stock to Underweight from Neutral with a $63 price target
- DuPont (DD) down 8% after completing the merger of its Nutrition & Biosciences business with IFF (IFF)
- Gogo (GOGO) down 2% after JPMorgan analyst Philip Cusick downgraded shares to Underweight from Neutral with a $10 price target
Symbols:
TSLA - $793.32 /
-42.95 (-5.14%)
VIE THCB NIO XPEV TMO - $509.61 /
+12.94 (+2.61%)
OTIS CNCE GSX DD GOGO IFF Keywords: Fly Intel, Wall Street, Top Stories, Stocks